US · Healthcare · Biotechnology
EPS came in at -0.91 against a street estimate of -0.91 — a beat of 0.0%.
Analysts rate SeaStar Medical Holding Corporation a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $10.00.
| Fund | Stake |
|---|---|
| Geode Capital Management, LLC | 1.29% |
| Vanguard Capital Management, LLC | 0.86% |
| UBS Group AG | 0.82% |
| Vanguard Fiduciary Trust Co | 0.36% |
| Jane Street Group LLC | 0.33% |
| Northern Trust Corp | 0.27% |
| PNC Financial Services Group Inc | 0.13% |
| Tower Research Capital LLC | 0.04% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for SeaStar Medical Holding Corporation — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.